Title | Author(s) | Issue date | ???itemlist.??? |
Combination chemotherapy with cisplatin-vinblastine in malignant mesothelioma | Tsavaris, N.; Mylonakis, N.; Karvounis, N.; Bacoyiannis, C.; Briasoulis, E.; Skarlos, D.; Pavlidis, N.; Stamatelos, G.; Kosmidis, P. | 24-Nov-2015 | - |
Docetaxel and gemcitabine combination, as first-line treatment, in patients with extensive disease small-cell lung cancer. A phase II study of the Hellenic Cooperative Oncology Group | Skarlos, D. V.; Dimopoulos, A. M.; Kosmidis, P.; Papakostas, P.; Pavlidis, N.; Bacoyiannis, C.; Kiamouris, C.; Klouvas, G.; Gogas, H.; Fountzilas, G.; Samantas, E. | 24-Nov-2015 | - |
Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: a phase II study conducted by the Hellenic Cooperative Oncology Group | Fountzilas, G.; Stathopoulos, G.; Nicolaides, C.; Kalogera-Fountzila, A.; Kalofonos, H.; Nikolaou, A.; Bacoyiannis, C.; Samantas, E.; Papadimitriou, C.; Kosmidis, P.; Daniilidis, J.; Pavlidis, N. | 24-Nov-2015 | - |
Paclitaxel by three-hour infusion and carboplatin in advanced carcinoma of nasopharynx and other sites of the head and neck. A phase II study conducted by the Hellenic Cooperative Oncology Group | Fountzilas, G.; Skarlos, D.; Athanassiades, A.; Kalogera-Fountzila, A.; Samantas, E.; Bacoyiannis, C.; Nicolaou, A.; Dombros, N.; Briasoulis, E.; Dinopoulou, M.; Stathopoulos, G.; Pavlidis, N.; Kosmidis, P.; Daniilidis, J. | 24-Nov-2015 | - |
Paclitaxel in combination with carboplatin or gemcitabine for the treatment of advanced head and neck cancer | Fountzilas, G.; Athanassiades, A.; Kalogera-Fountzila, A.; Samantas, E.; Bacoyiannis, C.; Briassoulis, E.; Pavlidis, N.; Kosmidis, P.; Skarlos, D. | 24-Nov-2015 | - |
Prognostic factors influencing complete response to treatment and survival of patients with nasopharyngeal cancer | Kalogera-Fountzila, A.; Kosmidis, P.; Bacoyiannis, C.; Nicolaou, A.; Samantas, E.; Briassoulis, E.; Pavlidis, N.; Skarlos, D.; Daniilidis, J.; Fountzilas, G. | 24-Nov-2015 | - |
Vinblastine and interferon-gamma combination with and without 13-cis retinoic acid for patients with advanced renal cell carcinoma. Results of two phase II clinical trials | Bacoyiannis, C.; Dimopoulos, M. A.; Kalofonos, H. P.; Nicolaides, C.; Aravantinos, G.; Bafaloukos, D.; Samelis, G.; Onyenadum, A.; Kiamouris, Ch; Skarlos, D.; Pavlidis, N.; Triantafillidis, A.; Kosmidis, P. | 24-Nov-2015 | - |
Vinorelbine versus paclitaxel for patients with advanced non-small cell lung cancer (NSCLC) and a performance status of 2 | Kosmidis, P. A.; Syrigos, K.; Kalofonos, H. P.; Dimopoulos, M. A.; Skarlos, D.; Pavlidis, N.; Boukovinas, I.; Bafaloukos, D.; Pectasides, D.; Bacoyiannis, C.; Fountzilas, G. | 24-Nov-2015 | - |